To test the involvement of immunoproteasome and its LMP2 R60H polymorphism in MS we investigated one of the major immunodominant self-epitopes detected in MS patient blood [13], [14], [15], i.e. MBP111–119 (HLA-A*0201-restricted). The gene discussed is PSMB9; the disease is myeloid sarcoma.